Literature DB >> 17327337

Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area.

Paul Ince1, Fran L Game, William J Jeffcoate.   

Abstract

OBJECTIVE: To examine the outcome of neuropathic foot ulcers and to seek associations between healing and features of the ulcers at baseline. RESEARCH DESIGN AND METHODS: Data were collected prospectively during the course of routine management. All patients were selected who presented to a single unit between 1 January 2000 and 31 December 2004 with neuropathic foot ulcers and without evidence of either peripheral arterial disease or infection. Associations were sought between ulcer characteristics at baseline and clinical outcome.
RESULTS: A total of 154 patients (66.9% male) presented with 410 ulcers. Age was 57.4 +/- 12.0 years (means +/- SD). A total of 178 (43.4%) ulcers were on the plantar aspect of the foot; 73.7% of ulcers had a cross-sectional area of <1 cm2. Median ulcer duration at referral was 15 days (range 1-1,046). Healing without amputation was observed in 91.7%. The percentage of ulcers healed at 12, 20, and 52 weeks were 59.3, 70.5, and 86.6%, respectively. Significant associations were observed between area at referral and outcome type (chi2 P < 0.0001), prior ulcer duration (Kruskal-Wallis P = 0.006), and time to healing (Kruskal-Wallis P = 0.014), as well as between ulcer duration and time to healing (Spearman rho, r = 0.104, P = 0.047). There was no difference between plantar and nonplantar ulcers.
CONCLUSIONS: The rate of healing in this cohort provides a benchmark for comparison with other centers. While further work is needed to determine how outcomes can be improved in unselected series such as these, the confirmation of close relationships between ulcer duration at referral, ulcer area, and outcome emphasizes the importance of early expert assessment of newly occurring neuropathic ulcers.

Entities:  

Mesh:

Year:  2007        PMID: 17327337     DOI: 10.2337/dc06-2043

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

1.  Stratification of foot risk predicts the incidence of new foot disease, but do we yet know that the adoption of routine screening reduces it?

Authors:  W J Jeffcoate
Journal:  Diabetologia       Date:  2011-02-18       Impact factor: 10.122

2.  Assessment of Simple Bedside Wound Characteristics for a Prediction Model for Diabetic Foot Ulcer Outcomes.

Authors:  Clara Bender; Simon Lebech Cichosz; Louise Pape-Haugaard; Merete Hartun Jensen; Susan Bermark; Anders Christian Laursen; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2020-07-22

Review 3.  Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Vivienne Chuter; Frank Quigley; Patrik Tosenovsky; Jens Carsten Ritter; James Charles; Jane Cheney; Robert Fitridge
Journal:  J Foot Ankle Res       Date:  2022-07-05       Impact factor: 3.050

4.  Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration.

Authors:  Timothy M Rankin; John D Miller; Angelika C Gruessner; D Scott Nickerson
Journal:  J Diabetes Sci Technol       Date:  2015-06-08

5.  Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes.

Authors:  Sue E Gardner; Ambar Haleem; Ying-Ling Jao; Stephen L Hillis; John E Femino; Phinit Phisitkul; Kristopher P Heilmann; Shannon M Lehman; Carrie L Franciscus
Journal:  Diabetes Care       Date:  2014-07-10       Impact factor: 19.112

6.  Surgical strategies for prevention of amputation of the diabetic foot.

Authors:  Robert G Frykberg; Christopher Attinger; Luuk Smeets; Armin Koller; Arun Bal; Venu Kavarthapu
Journal:  J Clin Orthop Trauma       Date:  2021-02-26

7.  The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration.

Authors:  Joerg Tautenhahn; Ralf Lobmann; Brigitte Koenig; Zuhir Halloul; Hans Lippert; Thomas Buerger
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study.

Authors:  Svetlana N Zykova; Ksenia A Balandina; Natalia V Vorokhobina; Alla V Kuznetsova; Rolf Engstad; Tatiana A Zykova
Journal:  J Diabetes Investig       Date:  2013-12-02       Impact factor: 4.232

9.  The current burden of diabetic foot disease.

Authors:  Michael Edmonds; Chris Manu; Prashanth Vas
Journal:  J Clin Orthop Trauma       Date:  2021-02-08

10.  Physical Therapy in Wound Care: A Cost-Effectiveness Analysis.

Authors:  Kehua Zhou; Kenneth Krug; Michael S Brogan
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.